78 results
Page 4 of 4
6-K
EX-99.1
c9tqx844tz97ds
22 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
fdi ihvho4oo6k
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.2
7bh50 dlrpmxgbqsbl
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.1
ms35wh2j0r
27 Feb 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99.1
zr4dt5l f08ztytlhjf
27 Feb 14
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress
12:00am
6-K
EX-99
26cq0cb
9 Jan 14
RepliCel to Commence Trading on the TSX Venture Exchange
12:00am
6-K
x40zg 4nzoz2l0j
20 Nov 13
Current report (foreign)
12:00am
6-K
EX-99.1
cdaj47fpgd ct0vln3bz
28 Aug 13
Current report (foreign)
12:00am
6-K
EX-99.2
5p3jgbsk 0yj6
12 Jul 13
Current report (foreign)
12:00am
6-K
EX-99.1
cais79s9r3ouxyf0v32
12 Jul 13
Current report (foreign)
12:00am
6-K
EX-99
83cwh40
6 Jun 13
Replicel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License
12:00am
6-K
EX-99
1xy7 xo1mf6ln
6 Jun 13
Replicel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License
12:00am
6-K
71peqpez38bf57bj
29 May 13
Current report (foreign)
12:00am
6-K
bwl q9lwbxa2i3z459r
1 May 13
Current report (foreign)
12:00am